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ABSTRACT 
 
Red raspberries, containing ellagitannins and cyanidin-based anthocyanins, were fed to volunteers 
and metabolites appearing in plasma and urine were analysed by UHPLC-MS. Anthocyanins were not 
absorbed to any extent with sub nmol/L concentrations of cyanidin-3-glucoside and a cyanidin-O-
glucuronide appearing transiently in plasma. Anthocyanins excreted in urine corresponded to 0.007% of 
intake. More substantial amounts of phase II metabolites of ferulic acid and isoferulic acid, along with 4′-
hydroxyhippuric acid, potentially originating from pH-mediated degradation of cyanidin in the proximal 
gastrointestinal tract, appeared in urine and also plasma where peak concentrations were attained 1-1.5 
h after raspberry intake.  Excretion of 18 anthocyanin-derived metabolites corresponded to 15.0% of 
intake, a figure substantially higher than obtained in other anthocyanin feeding studies.  Ellagitannins 
pass from the small to the large intestine where the colonic microbiota mediate their conversion to 
urolithins A and B which appeared in plasma and were excreted almost exclusively as sulfate and 
glucuronide metabolites.  The urolithin metabolites persisted in the circulatory system and were 
excreted in urine for much longer periods of time than the anthocyanin metabolites although their 
overall urinary recovery was lower at 7.0% of intake.  It is events originating in the proximal and distal 
gastrointestinal tract, and subsequent phase II metabolism, that play an important role in the 
bioavailability of both anthocyanins and ellagitannins and it is their metabolites which appear in the 
circulatory system, that are key to elucidating the mode of action(s) underlying the protective effects of 
these compounds on human health.   
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Introduction 
Red raspberries (Rubus idaeus L.) are a rich source of polyphenolic compounds, the main 
components being anthocyanins and ellagitannins [1]. There is growing evidence linking consumption of 
these compounds with beneficial effects on human health: anthocyanins, such as cyanidin-3-O-glucoside, 
have cardioprotective effects [2], while ellagitannins exhibit anti-inflammatory and anti-cancer 
properties [3]. However, the mechanisms involved remain poorly understood principally because of a 
limited understanding of the absorption, disposition, metabolism and excretion (ADME), synonymous 
with bioavailability in nutrition research, of ellagitannins and anthocyanins.  
Ellagitannins, which occur in raspberries as well as other berries and fruits [4], are not absorbed 
per se but are subjected to the action of the colonic microbiota releasing ellagic acid that is converted to 
urolithins which are absorbed into the circulatory system mainly as sulphate and glucuronide phase II 
metabolites [5, 6]. Anthocyanins are widely reported to have low bioavailability, with the majority of 
studies recording peak plasma concentrations (Cmax) ranging from 1 to 120 nmol/L [7] and urinary 
recoveries <2% of intake [8,9]. Much lower levels of excretion were evident after feeding Concord grape 
juice [10] while Wu et al. [11] reported a urinary recovery of blueberry anthocyanins fed to elderly 
women corresponding to 0.004% of intake. However, a recent study has shown extensive colonic 
microbiota-mediated degradation of 13C5-labeled cyanidin-3-O-glucoside which resulted in the 
production of a wide range of phenolic metabolites over a 0-48 h period. Relative bioavailability assessed 
by recovery of the 13C-label was 6.9% in breath as CO2, with 5.4% in urine and 32% in feces in the form of 
13C-labeled phenolic and aromatic compounds [12,13].  Unlike other (poly)phenols, anthocyanins are 
subject to pH-dependent transformations before reaching the large bowel [14]. The early presence of 
anthocyanin breakdown products in the bloodstream could be associated with chemical decomposition 
at neutral pH [15] as well as first pass metabolism in the intestinal wall and/or the liver [16]. 
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Potential in vivo health effects of anthocyanins are almost certainly the consequence of the 
presence of their metabolites in the circulatory system rather than the parent compounds that are 
present in the ingested foods, and the same applies to ellagitannins. An understanding of the ADME of 
anthocyanins and ellagitannins is, therefore, crucial for the elucidation of the mechanisms responsible 
for the health benefits of raspberry polyphenols. This study used UHPLC-MS to further explore the 
identity and amounts of the phenolic metabolites of anthocyanins and ellagitannins in human plasma 
and urine following acute ingestion of raspberries, building on earlier studies by González-Barrio et al. 
[5,6]. 
 
Materials and methods 
Chemicals and reagents 
Raspberries cv. Glen Magna were obtained from a commercial grower in Angus, U.K. Cyanidin-3-O-
glucoside, ellagic acid, ferulic acid, 3’-methoxy-4’-hydroxyphenylacetic acid (aka homovanillic acid), 3’,4’-
dihydroxyphenylacetic acid, 3-methoxy-4-hydroxybenzoic acid (aka vanillic acid), 4-hydroxybenzoic acid, 
3,4-dihydroxybenzoic acid (aka protocatechuic acid), hippuric acid, acetic acid and formic acid were 
purchased from Sigma-Aldrich (Poole, Dorset, U.K.). 3’,4’-Dihydrocaffeic acid-3’-sulfate (aka 4′-
hydroxyphenylpropionic acid-3’-sulfate), ferulic acid-4’-O-sulfate and isoferulic acid-3’-O-D-glucuronide, 
were obtained from Toronto Research Chemical, (Toronto, Canada). Urolithin A, urolithin B and urolithin 
B-3-O-glucuronide were provided by Prof. O. Dangles (INRA, Avignon, France). HPLC grade solvents were 
obtained from Fisher Scientific (Loughborough, UK). 
 
Study protocol 
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The study and protocol were approved by the West of Scotland Research Ethics Service (ref: 
12/WS/0192) and registered at ClinicalTrials.gov  (NCT02520596).  The criteria for volunteers to 
participate in the study were to be in good health, a non-smoker, not taking any medication or 
nutritional supplement, not being pregnant or breast feeding. Ten volunteers (5 female, 5 male) were 
recruited and gave their written consent to participate in this study. One male volunteer subsequently 
withdrew from the study. The remaining 9 volunteers were aged between 22 and 44 years, with an 
average height of 1.72 ± 0.10 m (mean ± SD), an average weight of 73.3 ± 17.0 kg, and a mean body mass 
index of 24.6 ± 5.0 kg/m. Subjects were required to follow a diet low in (poly)phenolic compounds by 
avoiding fruits and vegetables, nuts, high-fibre products, and beverages such as tea, coffee and fruit 
juices, as well as to abstain from consuming alcohol, for 48 h prior to and during the study. Following an 
overnight fast, the volunteers consumed 300 g of homogenized raspberries and, except for water intake 
to maintain adequate levels of hydration, but no other food or drink was allowed for the next 3 h. Lunch 
was provided and consisted of a selection of white rolls, ham, margarine spread, cheese and ready salted 
crisps. Volunteers continued the low (poly)phenolic diet for a further 48 h. All urine excreted for 12 h 
prior to supplementation was collected in acidified methanol as well as that excreted over 48 h after 
ingestion of raspberries which was collected over the following periods: 0-4 h, 4-8 h, 8-24 h, 24-32 h and 
32-48 h. Blood samples were collected in heparin tubes before (0 h) and after raspberry consumption at 
0.5 h, 1 h, 1.5 h, 2 h, 3 h, 4 h, 5 h, 6 h, 8 h, and 24 h. Plasma obtained by centrifugation of whole blood at 
2000 g for 15 min at 5°C, was separated into 1mL aliquots which were acidified to pH 3 with 15 μL of 50% 
formic acid, and stored at -80°C. The volumes of urine excreted were measured, and aliquots were 
stored at -80°C. 
 
Extraction of raspberries 
Five grams of raspberries were homogenised in 15 mL of methanol/water/formic acid (75:25:1, 
v/v/v) and ultrasonicated for 1 h at 5°C. Samples were then centrifuged at 5°C for 10 min at 4000 g and 
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10 μL of the supernatant analysed by HPLC with photodiode array (PDA) and mass spectrometric (MS) 
detection. 
 
Processing of urine and plasma 
Urine samples were defrosted, adjusted to pH 2.5, vortexed, centrifuged at 16110 g for 10 min at 
5°C, and passed through 0.45 μm filter discs prior to the analysis of 5 μL aliquots by UHPLC-MS.  
Plasma samples were defrosted, vortexed and 400 µL aliquots were mixed with 1 mL of 2% 
formic acid in acetonitrile. The samples were then vortexed and ultrasonicated for 10 min. After 
centrifugation at 16110 g for 10 min, supernatants were reduced to dryness in vacuo using a Speedvac 
concentrator (Thermo Scientific Inc., San Jose, CA) and resuspended in 100 µL of methanol:water:formic 
acid (50:50:0.1, v/v/v) which was centrifuged at 16100 g for 10 min and 5 μL aliquots of the supernatant 
analysed by UHPLC-MSn and UHPLC- MS2.  
 
Qualitative and quantitative analysis of anthocyanins, ellagic acid and ellagitannins in raspberries by 
HPLC-PDA-MS2 
Quantitative analysis of (poly)phenols in raspberries was carried out using a Surveyor HPLC 
(Thermo Scientific Inc.) with an autosampler cooled at 6°C and a PDA detector scanning from 200-
600 nm. The injection volume was 10 µL. Chromatography was carried out at 40°C using a Synergy 4 µm 
Polar-RP 250 x 4.6 mm, reversed phase column (Phenomenex, Macclesfield, UK). The mobile phase, 
pumped at a flow rate of 1 mL/min, was (A) water/trifluoroacetic acid (99:1, v/v) and (B) methanol/ 
trifluoroacetic acid (99:1, v/v). The gradient started with 10% B at time 0 min and reached 45% B after 70 
min. Chromatograms were recorded at 280, 365 and 520 nm.  
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Identifications were confirmed using the same instrument but after passing through the PDA 
detector flow cell, the eluate was split and 0.3 mL/min directed to a LCQ Advantage ion trap mass 
spectrometer fitted with an electrospray interface (ESI) (Thermo Scientific Inc.). The mobile phase, 
pumped at a flow rate of 1mL/min, was water/ formic acid (99:1, v/v) (A) and methanol/formic acid 
(99:1, v/v) (B). The gradient started with 10% B at time 0 min and reached 45% B at 70 min. The mass 
spectrometer was operated in positive ionization mode for anthocyanin analysis and in negative 
ionization for ellagitannin and ellagic acid identifications. Capillary temperature was 300°C, sheath gas 
flow was 40 units, while the auxiliary gas was set to 10 units. In negative ionization mode the source 
voltage was 3 kV. The capillary and tube lens voltage were 4 and 25 V, respectively. When used in 
positive ionization mode the source voltage was 3.5 kV, while capillary and tube lens voltage were -30 
and -60 V, respectively. Analysis was initially carried out in full-scan, data-depending scanning from m/z 
150 to 2000 and identification was confirmed by selected reaction monitoring (SRM). Data processing 
was performed using Xcalibur software (Thermo Scientific). 
Anthocyanins were quantified by PDA at 520 nm, and expressed as cyanidin-3-O-glucoside 
equivalents, whereas ellagitannins and ellagic acid conjugates were quantified at 280 nm and 365 nm, 
respectively, and expressed as ellagic acid equivalents. 
 
Qualitative and quantitative analysis of ellagic acid, urolithins and phenolic acid derivatives in urine and 
plasma samples by UHPLC-MS2 
Ellagic acid, urolithins and phenolic derivatives were analysed using a DIONEX Ultimate 3000 
UHPLC equipped with a TSQ Vantage triple quadrupole mass spectrometer fitted with a heated-ESI 
(Thermo Scientific Inc.).  For UHPLC, mobile phase A was 0.5% formic acid in water and mobile phase B 
was acetonitrile containing 0.5% formic acid. Separations were performed with a Kinetex PFP (50 × 2.1 
mm), 2.6 μm particle size, column (Phenomenex). The gradient started with 1% B, isocratic conditions 
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were maintained for 1 min, and reached 40% B after 15 min, followed by 2 min at 80% B and then 4 min 
at 1% B to re-equilibrate the column. The flow rate was 0.3 mL/min, the injection volume was 5 μL, and 
the column temperature was at 35°C. 
The applied MS method consisted in the selective determination of each target precursor ion by 
the acquisition of characteristic product ions in SRM mode, with negative ionization. The capillary 
temperature was 270 °C, and the source was operated at 200 °C. The sheath gas flow was 50 units, and 
auxiliary gas pressure was set to 5 units. The source voltage was 3 kV. Ultra high-purity argon gas was 
used for collision-induced dissociation (CID). Data processing was performed using Xcalibur software 
(Thermo Scientific Inc.).  
Quantification was performed with calibration curves of standards, when available. 
Dimethylellagic acid glucuronide, (iso)urolithin A-O-glucuronides and sulfoglucuronide were quantified in 
urolithin-B-3-O-glucuronide equivalents. Urolithin-A sulfate was expressed as urolithin A equivalents, 
while isoferulic acid-3’-O-glucuronide and 3′-sulfate were quantified respectively as ferulic acid-4’-O-
glucuronide and 3′-sulfate  equivalents.  Hydroxybenzoic acid-sulfates and caffeic acid-3′-sulfate were 
quantified as dihydrocaffeic acid-3’-sulfate equivalents and  4'-hydroxyhippuric acid by reference to a 
hippuric acid standard curve. 
 
Qualitative and quantitative analysis of anthocyanins in urine and plasma samples by UHPLC-MS  
Anthocyanins were analysed using an Accela UHPLC 1250 with a LTQ XL linear ion trap-mass 
spectrometer fitted with a heated-ESI probe (Thermo Scientific Inc.). Separation was performed with a 
Kinetex PFP (50 × 2.1 mm), 2.6 μm particle size column (Phenomenex, Macclesfield, UK). The volume 
injected was 5 µL and column oven was set to 30°C. Elution was carried out at a flow rate of 0.2 mL/min. 
The gradient started with 10% acetonitrile in 0.1% aqueous formic acid, and after 1 min a 9-min linear 
gradient of 10% to 60% acetonitrile was applied. From 10 to 11 min the acidified acetonitrile increased to 
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80%, and after 2 min was reduced to 10% acetonitrile to re-equilibrate the column. The MS was 
operated in positive ionization mode with a capillary temperature of 275°C, with the source temperature 
of 300°C. The sheath gas flow was 40 units and the auxiliary gas set to 5 units. The source voltage was 
4.5 kV. The capillary and tube lens voltage were 20 and 95 V, respectively. Analyses were carried out 
using full scan, data-dependent MS3 scanning from m/z 100 to 600, with CID of 35 (arbitrary units). 
Helium gas was used for CID. Data processing was performed using Xcalibur software (Thermo Scientific). 
Anthocyanins were quantified using a cyanidin-3-O-glucoside calibration curve. 
 
Statistical analysis 
Results are presented as mean values ± standard error. For all metabolites found in urine prior to 
supplementation, paired comparisons between baseline values and post-supplementation values on an 
excretion per hour basis were performed using the Wilcoxon matched-pairs signed rank test. Differences 
were considered significant at p ≤ 0.05. All statistical analyses were performed using the STATA v.12.0 
software package. 
 
Results 
(Poly)phenol content of raspberries 
A total of 8 anthocyanins, 2 ellagic acid conjugates, 3 ellagitannins, 1 hydroxycinnamate and 1 
phenolic acid were identified and quantified in the raspberry supplement (Table 1). HPLC retention times 
and mass spectra of the compounds detected are presented in Table S1 of the Supplementary 
Information. The main anthocyanins were cyanidin-3-O-sophoroside, cyanidin-3-O-(2”-O-
glucosyl)rutinoside, cyanidin-3-O-glucoside and cyanidin-3-O-rutinoside. Sanguiin H-6 was the principal 
ellagitannin followed by lambertianin C and a much lower amount of sanguiin H-10. Small quantities of 
an ellagic acid-O-pentoside and an ellagic acid-O-hexoside were also detected along with trace amounts 
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of ferulic acid and 4-hydroxybenzoic acid.  The berries did not contain detectable quantities of either 
caffeoylquinic, feruloylquinic or p-coumaroylquinic acids.  The 300 g of blended raspberries consumed by 
the volunteers contained, in total, 553 μmol of (poly)phenols of which anthocyanins comprising 53% and 
ellagitannins 45%, with ellagic acid conjugates, ferulic acid and 4-hydroxybenzoic acid making up the 
remaining 2% (Table 1). For structures see Fig. 1.  
 
Excretion of (poly)phenol metabolites in urine 
A total of 27 compounds were detected in urine over the 48 h collection period after ingestion of 
raspberries and typical UHPLC-MS-SRM traces illustrated in Fig. 2. The HPLC retention times and mass 
spectra of 23 of these compounds and their occurrence urine and plasma are presented in Table S2 of 
the Supplementary Information.   
Table 2 summarizes quantitative aspects of the urinary excretion of anthocyanins and their 
phenolic metabolites. None of the parent anthocyanins were detected except for low nmol levels of 
cyanidin-3-O-glucoside excreted during the first 24 h. In addition, trace levels of peonidin-3-O-glucoside 
were found in the 0-4 h and 4-8 h urine samples. This 3'-O-methyl analogue of cyanidin-3-O-glucoside 
was not present in raspberries and its appearance in urine points towards in vivo methylation as a minor 
step in anthocyanin metabolism.  
A further 16 phenolic metabolites derived from anthocyanins were detected in urine, namely 4-
hydroxybenzoic acid, 3,4-dihydroxybenzoic acid, 3-methoxy-4-hydroxybenzoic acid, 4-hydroxybenzoic 
acid-3-sulfate, 3-hydroxybenzoic acid-4-sulfate, 3’,4'-dihydroxyphenylacetic acid, 3’-methoxy-4’-
hydroxyphenylacetic acid, 4’-hydroxyhippuric acid, hippuric acid, caffeic acid-3′-sulfate, dihydrocaffeic 
acid-3’-sulfate, ferulic acid, and sulfated and glucuronidated metabolites of ferulic acid and isoferulic acid 
(Table 2). These metabolites were excreted in much higher amounts than the anthocyanins themselves. 
Low levels of certain phenolic acids were detected in baseline urine collected over 12 h before raspberry 
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consumption and the amounts of these compounds detected over the 0-48 h of the study were used to 
correct for baseline excretion. Benzoic acid and phenylacetic acid derivatives were detected in the urine 
of some but not all volunteers, with 4-hydroxybenzoic acid, 2 hydroxybenzoic acid sulfates, 3’4’-
dihydroxyphenylacetic acid, and 3’-methoxy-4’-hydroxyphenylacetic acid present in quantifiable 
amounts. Total 0-48 h excretion of benzoic acid and phenylacetic acid derivatives was respectively 6.9 ± 
5.0 and 3.1 ± 1.7 μmol,. 
Caffeic acid-3′-sulfate and dihydrocaffeic acid-3’-sulfate were identified and quantified in all 
volunteers with a total urinary excretion of 1.0 ± 0.1 μmol and 1.1 ± 0.3 μmol over 48 h post-
consumption. Other urinary phenylpropanoid derivatives were detected in urines from all volunteers 
with a total 0-48 h excretion of 17.8 ± 5.3 μmol (Table 2). 4'-Hydroxyhippuric and hippuric acid were also 
present in urine collected from all the volunteers after raspberry intake with total 0-48 h excretion 
values of 16.1 ± 1.9 μmol, and 239 ± 55 μmol, respectively. Although hippuric acid, formed by hepatic 
glycination of benzoic acid, has been described as a common metabolite of many flavonoids [17], it was 
not included in the calculation of the percentage recovery because its high background levels, originating 
from other dietary and endogenous sources  [18-20], make it difficult to determine the amounts derived 
from the metabolism of anthocyanins. Thus, the overall recovery of anthocyanins and their metabolites 
observed in this study was 43.9 ± 8.0 μmol which corresponds to 15.0% of anthocyanin intake (Table 2). 
In contrast to anthocyanins and their metabolites, no ellagitannin metabolites were detected in 
the 0-4 h and 4-8 h urine samples. Low levels of urolithins A and B were detected in 8-48 h urine while 
there were much larger amounts of their phase II metabolites, namely a urolithin A-O-glucuronide, a 
urolithin A-sulfate and urolithin  B-3-O-glucuronide with total 8-48 h excretion of 3.4 ± 1.2 μmol, 6.7 ± 
3.2 μmol, and 5.2 ± 2.6 μmol, respectively  (Table 3). Substantial inter-individual differences were 
observed.  Urolithin A-O-glucuronide and urolithin-B-3-O-glucuronide were found in urine from all 
volunteers but the amounts varied considerably, with 0-48 h excretion ranging from 0.4 to 11 μmol and 
0.3 and 24 μmol, respectively. Urolithin A-sulfate was produced by 8 volunteers and in amounts ranging 
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from 0.9 to 30 μmol. Five out of 9 volunteers produced urolithin A-sulfate-O-glucuronide with excretion 
values ranging between 1.0 and 1.6 μmol while isourolithin A-O-glucuronide was produced only by 4 
volunteers with total excretion between 0.4 and 3.6 μmol.  
From the 257 μmol of ingested ellagitannins and ellagic acid conjugates, 17.9 ± 4.0 μmol were 
recovered in 0-48 h urine as ellagic acid and urolithin derivatives which represents 7.0 % of intake.  
 
Analysis of plasma 
 A total of 15 compounds were identified and quantified in plasma, and pharmacokinetic 
parameters of each compound, except for hippuric acid, are summarized in Tables 4 and 5. Typical 
UHPLC-MS traces of plasma metabolites are illustrated in Fig. S1 of the Supplementary Information. Two 
anthocyanins were detected in sub-nmol/L levels. Their pharmacokinetic profiles are illustrated in Fig. 3. 
Cyanidin-3-O-glucoside was present in the samples of 7 volunteers and reached a peak plasma 
concentration (Cmax) of 0.2 ± 0.1 nmol/L 1.0 h after ingestion of raspberries. The individual values ranged 
between 0.1 and 0.7 nmol/L. A cyanidin-O-glucuronide, which was not detected in urine, was found in 
the plasma of 3 volunteers at 2 h, 4 h, and 6 h, at concentrations that ranged from 0.1 to 0.3 nmol/L.  
Peonidin-3-O-glucoside which occurred in low amounts in urine (Table 2) was not detected in plasma. 
The raspberries contained low levels of two pelargonidin-3-O-glycosides (Table 1) but, unsurprisingly, no 
pelargonidin-based anthocyanins were detected in either plasma or urine. 
Three ferulic acid metabolites were identified and quantified in plasma samples from all 9 
volunteers (Table 4). Pharmacokinetic profiles of these compounds are presented in Fig. 4. The Cmax of 
ferulic-4’-O-sulfate was 47 ± 14 nmol/L and the time to reach Cmax (Tmax) was 1 h after the consumption 
of raspberries. The 2 glucuronide derivatives, ferulic acid-4’-O-glucuronide and isoferulic-3’-O-
glucuronide, had a Tmax of 1.5 h with Cmax values of 18 ± 2 nmol/L and 14 ± 2 nmol/L, respectively. At 24 h 
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these hydroxycinnamate metabolites were still present in plasma albeit at substantially reduced 
concentrations (Fig. 4). 
Hippuric acid and 4’-hydroxyhipurric acid were found in all plasma samples. While 
pharmacokinetic profile of the predominant component, hippuric acid, showed a more or less steady 1-2 
µM concentration throughout the study, 4’-hydroxyhippuric acid had a Cmax of 78 ± 12 nmol/L 1 h after 
raspberry intake (Table 4, Fig. 5). 3’,4’-Dihydroxyphenylacetic acid was found in plasma samples of 7 
volunteers and attained a mean Cmax of 180 ± 89 nmol/L after 6 h (Fig. 4, Table 4) and at 24 h was still 
present in the plasma of 3 volunteers at concentrations of 174-387 nmol/L.  
Six metabolites derived from the ingested ellagitannins and ellagic acids were quantified in 
plasma, namely, a dimethylellagic acid-O-glucuronide, 2 urolithin A-O-glucuronide isomers (urolithin A-O-
glucuronide and isourolithin A-O-glucuronide), urolithin A-sulfate, (iso)urolithin A-sulfate-O-glucuronide 
and urolithin B-3-O-glucuronide (Table 5). Their pharmacokinetic profiles are illustrated in Fig. 6. 
Dimethylellagic acid-O-glucuronide was found in plasma samples from all volunteers and appeared at 
low concentrations after 2 h with more substantial amounts present from 3 h onwards. The Cmax of this 
ellagic acid metabolite, 4.1 ± 1.0 nmol/L, was reached 8 h after raspberry consumption (Fig. 6, Table 5). 
However, levels ranging from 1.5 to 15 nmol/L, were detected in the plasma of 3 volunteers 24 h after 
raspberry intake.  All 5 urolithin derivatives detected in plasma showed highest concentrations at 24 h 
(Fig. 6) and, as with their urinary excretion, there was considerable inter-individual differences.  For 
instance, the major metabolite urolithin A-sulfate, which was present in the plasma of 8 volunteers, with 
individual  Cmax values ranging from 121 to 1591 nmol/L and a mean of 450 ± 161 nmol/L (Fig. 6, Table 5). 
There were similar person-to-person variations in the plasma profiles of the other 4 urolithin 
metabolites.   
 
Discussion 
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In this study the ADME of anthocyanins and ellagitannins, was investigated by using UHPLC-MS to 
analyse plasma and urine collected after the acute ingestion of 300 g of blended raspberries. From the 
total of 25 compounds identified in urine, 17 were anthocyanin-derived compounds and 8 were 
metabolites of ellagitannins. Analysis of plasma samples led to the identification of 9 anthocyanin 
metabolites and 6 ellagitannin metabolites. 
Except for low amounts of cyanidin-3-O-glucoside, no parent raspberry anthocyanins were 
detected in plasma or urine arguably because they were almost all di-and trisaccharides (see Table 1 and 
Fig. 1) and as such, without cleavage of the sugar moieties, are unlikely to be absorbed in even trace 
quantities [7]. Cyanidin-3-O-glucoside exhibited extremely low plasma concentrations with a Cmax of 0.2 
nmol/L reached 1 h post-consumption (Fig. 3, Table 4) and the highest amount, 9.3 ± 5.4 nmol, was 
excreted in urine 0-4 h after raspberry intake (Table 2). These results are in keeping with other reports 
on low amounts of anthocyanins in their native form appearing in plasma and urine following absorption 
from the proximal gastrointestinal tract (GIT) [10,21]. In the current study, very small amounts of two 
phase II metabolites of cyanidin-3-O-glucoside were detected in plasma and urine. Peonidin-3-O-
glucoside, the methylated analogue of cyanidin-3-O-glucoside, was found in urine at 0-4 h and 4-8 h.  A 
cyanidin-O-glucuronide appeared in the plasma of 3 subjects peaking 2-4 h post-ingestion (Fig. 3, Table 
4). However, the low amounts of these phase II metabolites indicate they are not major metabolites of 
anthocyanins.  
The levels of anthocyanins in plasma (Fig. 3) were substantially lower than those observed by de 
Ferrars et al. after the ingestion of a 1,114 μmol bolus of [13C5]cyanidin-3-O-glucoside [13].  This could be 
due, in part, to a matrix effect but is probably a reflection of the relatively low 37 μmol cyanidin-3-O-
glucoside content of the raspberry supplement (see Table 1).  From a quantitative perspective, of the 
292 μmol of anthocyanins ingested only 21.3 nmol were excreted in 0-48 h urine which corresponds to a 
recovery of 0.007%. Even when related to the 37 μmol cyanidin-3-O-glucoside intake (Table 1), 
anthocyanin excretion (Table 2) was equivalent to only 0.06% of intake. 
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Compared with anthocyanins, much more substantial amounts of phenolic metabolites were 
detected in plasma and urine. Anthocyanins undergo pH-mediated degradation in the distal GIT [14] 
forming A-ring derived phloroglucinaldehyde, and hydroxylated and methylated benzoic acid derivatives 
depending upon the substituent group(s) on the B-ring [22,23]. In the case of cyanidin and pelargonidin, 
putative B-ring-derived degradants are, respectively, 3,4-dihydroxybenzoic acid and 4-hydroxybenzoic 
acid [6,15]. However, these phenolic acids were not detected in plasma and only small quantities were 
excreted in urine (Table 2). Similarly, only small amounts of two sulfated hydroxybenzoic acids were 
found only in urine while the corresponding glucuronides were not detected, in contrast to the results 
obtained after ingestion of [13C5]cyanidin-3-O-glucoside, albeit at a markedly higher intake [13]. 
The main plasma phenolic acid was 3’4’-dihydroxyphenylacetic acid (Fig. 5, Table 4). Although 
variable amounts were also found at earlier time points indicating that the phenylacetic acid might be 
formed and absorbed to some extent in the small intestine, its Cmax of 180 ± 89 nM was reached at 6 h 
pointing towards absorption in the distal GIT after transformation of cyanidin-based anthocyanins by 
colonic microbiota.  
Ferulic and isoferulic acid metabolites were detected in plasma with a Cmax at 1-1.5 h (Table 4) and 
an apparent secondary, minor increase in plasma concentration at 6-8 h, with trace amounts still present 
after 24 h (Fig. 4). The amounts excreted, 15.7 μmol, were well in excess of the 1.2 μmol of ferulic acid 
present in the 300 g raspberry supplement so the majority of these phenylpropenoic acid metabolites 
must have been originated from a different source.  Ferulic acid and isoferulic acid metabolites form 
after ingestion of coffee containing caffeoylquinic acids [24] but the raspberry supplement did not 
contain detectable quantities of either caffeoylquinic, feruloylquinic or p-coumarylquinic acids (Table 1), 
so this route is implausible.  Although hydroxycinnamates have been proposed to be produced from 
anthocyanins as a result of bacterial-mediated cleavage of the B-ring in the colon [25], the 
pharmacokinetic profiles in Fig. 4 indicate that most absorption of ferulic acid derivatives takes place in 
the proximal rather than the distal GIT.  This is supported by the rapid appearance of B-ring-derived 
17 
 
[13C2]ferulic acid in the circulatory system after the ingestion of a [13C5]cyanidin-3-O-glucoside [13]. In the 
current raspberry study, pH-mediated breakdown of cyanidin in the small intestine could result in the 
formation of caffeic acid which, the findings of Stalmach et al. [24] indicate, is converted to ferulic acid 
and isoferulic acid and their phase II metabolites via enterocyte-based methylation and 
sulfation/glucuronidation steps.  Although urinary excretion of caffeic acid-3′-sulfate increased after 
raspberry consumption (Table 2), free caffeic acid was not detected in either plasma or urine, arguably as 
consequence of a rapid rate of turnover.  
Two glycine conjugates of benzoic acids were found in plasma and urine of all volunteers, namely 4’-
hydroxyhippuric and hippuric acid. 4’-Hydroxyhippuric acid reached Cmax 1 h post-ingestion (Fig. 6, Table 
4) pointing towards upper GIT absorption and rapid hepatic glycination of 4’-hydroxybenzoic acid. Low 
amounts of 4-hydroxybenzoic acid (2.3 μmol/300 g) were detected in the raspberry supplement (Table 1) 
and might have contributed to the pool of the glycinated benzoic acid derivative. However, the relatively 
high level of urinary excretion of 4’-hydroxyhippuric acid, 16.1 μmol, compared to the traces amounts of 
4-hydroxybenzoic acid in raspberries suggest that the hydroxylated hippuric acid is formed in the body 
by an alternative route. One possibly is via 3-dehydroxylation of cyanidin-derived 3,4-dihydroxybenzoic 
acid in the proximal GIT, followed by side chain glycination. In keeping with its plasma pharmacokinetic 
profile (Fig. 6), almost 65% of the excretion of 4’-hydroxyhippuric acid occurred 0-8 h post-ingestion 
(Table 2) reflecting a rapid clearance from the body.   
Potential pathways for the in vivo metabolism of the cyanidin-based anthocyanins are summarised 
in Fig. 7. 
Stable isotope-labelled hippuric acid has been reported as a metabolite of [13C5]cyanidin-3-O-
glucoside in humans [12]. However, as noted earlier, hippuric acid is also produced from other dietary 
and endogenous sources, which results in high background levels that can vary substantially from one 
volunteer to another. As a consequence, the absence of an isotopic label in the present study made it 
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impossible to determine to what extent degradation of cyanidin-based anthocyanins contributed to the 
quantity of hippuric acid excreted after raspberry supplementation. Hippuric acid excretion in urine was, 
therefore, not taken into account when calculating the 15.0% urinary recovery of anthocyanin-derived 
products (Table 2).  None-the-less, this is well in excess of the 5.4% urinary recovery of [13C5]cyanidin-3-
O-glucoside-derived metabolites reported by Czank et al. [12]. Arguably, this is a consequence of the 
raspberry matrix coupled with an anthocyanin intake of 292 μmol in the current study compared with 
the 1114 μmol in the Czank et al. study.  
A previous raspberry feeding study with ileostomist revealed a 23% recovery of the ellagitannin, 
sanguiin H-6, in ileal fluid. In volunteers with a functioning colon this would pass from the small to the 
large intestine where it would be subject to the action of the microbiota releasing ellagic acid that is 
further converted to urolithins [5,6] which are absorbed and subjected to phase II sulfation or 
glucuronidation, seemingly in the liver [26,27].  In the current investigation, after the consumption of 
raspberries containing 257 μmol of ellagitannins and ellagic acids, no parent compounds were detected 
in either plasma or urine which is in agreement with previous bioavailability studies [5, 28, 29]. The first 
ellagitannin-derived metabolite detected in plasma was a dimethylellagic acid-O-glucuronide, which 
appeared in trace amounts 2 h post-ingestion, with more substantial amounts occurring from 3 h 
onwards and reaching Tmax at 8 h (Fig. 6, Table 3). 
In addition to the dimethylellagic acid-O-glucuronide, 5 urolithin metabolites were detected in 
plasma with their concentrations increasing from 8 h onwards with highest levels being found 24 h post-
raspberry intake (Fig. 6, Table 5). As 24 h was the last blood sampling time point, the pharmacokinetic 
profiles obtained do not allow a determination of the time that Cmax was reached. Urolithins in urine 
were first detected in 8-24 h samples, consistent with their formation in the large intestine, and highest 
amounts were excreted 32-48 h after supplementation indicating that the plasma Cmax was attained >24 
h after raspberry intake. The urinary and plasma pharmacokinetics of the urolithins demonstrate their 
persistence in the body after consumption of ellagitannin-rich foods. Similar results were obtained in 
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previous bioavailability studies with ellagitannins [29,30]. Espin et al. [31] conducted a study in which 
pigs were fed acorns, a rich source of ellagitannins, and it was found that large amounts of urolithin 
metabolites accumulated in the gall bladder. These results are indicative of enterohepatic recirculation 
and could explain the prolonged presence of urolithin metabolites in the circulatory system observed in 
this (Fig. 6) and other human studies. 
While methylated anthocyanin metabolites, arguably formed mainly in the proximal GIT, were 
produced in sizable amounts (Table 2, Fig. 3), colon-derived dimethylellagic acid-O-glucuronide was the 
sole methylated ellagic acid/ellagitannin metabolite.  This raises the possibility that methylation is less 
prevalent in the large intestine than the upper GIT and, likewise, that there is minimal hepatic 
methylation of metabolites.   
Urolithins are formed in the distal GIT as the result of microbial degradation of ellagitannins and 
person-to person variations in the composition of the colonic microflora would appear to have a 
considerable impact on ellagitannin metabolism and bioavailability [5,6]. It has been reported that two 
human intestinal Gordonibacter species, G. urolithinfaciens and G. pamelaeae are able to convert 
ellagitannins and ellagic acid-derived compounds to urolithins [32]. Thus, biological activities ascribed to 
ellagitannin-rich foods, such as anti-inflammatory and anti-carcinogenic properties [33,34], may differ 
substantially depending on an individual’s gut microbiota. Oral supplementation with urolithins might be 
considered as a potential strategy to overcome their selective production and make their putative health 
benefits available to a wider population [35]. 
In addition to their specific anti-inflammatory activity, urolithins have also been shown to be 
potential candidate modulators of redox status. They have strong antioxidant properties in defined in 
vitro conditions, but behave mostly as pro-oxidants in cell-based assays ]36]. In agreement with this 
observation, in a cellular experimental bladder cancer model with T24 cells, urolithins were able to 
decrease intracellular reactive oxygen species and malonaldehyde levels, and to increase superoxide 
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dismutase activity when the cells were treated with H2O2, acting, therefore, as direct and indirect 
antioxidants [37]. 
While the current study has provided more detailed information on the ADME of raspberry 
anthocyanins and ellagitannins than earlier investigations [5,6], especially with regard to plasma 
pharmacokinetics of metabolites, it is noteworthy that the profiles of urinary metabolites, while similar, 
are not identical to those obtained in the earlier investigations.  This could, in part, be due to the use of 
HPLC-MS and GC-MS to analyse samples in the earlier studies compared to the different UHPLC-MS 
systems with enhanced sensitivity in the current investigation. However, another contributory factor is 
likely to be variations in the colonic microbiota of the volunteers participating in the different studies.  A 
comparison of the baseline levels of hippuric acid excreted prior to supplementation in different 
investigations indicates this is a more substantial factor than previously envisaged. For instance, in 
studies with black tea the reported 0-24 h baseline levels of hippuric acid excretion have been 597 ± 98 
μmol [38], 1.89 ± 0.28 mmol [39] and 2.5 ± 0.2 mmol [40].  In bioavailability studies carried out in 
Glasgow with different supplements, 24 h baseline hippuric acid excretion have been 137 ± 43 μmol [41], 
243 ± 38 μmol [42], and 589 ± 95 μmol [6]. In line with these values, in a recent Glasgow-based orange 
juice bioavailability study, baseline excretion of hippuric acid was 232 ± 21 μmol/24 h [43].  In contrast, 
an orange juice study using Glasgow protocols that was carried out in Adelaide, in collaboration with 
Australian colleagues, produced baseline hippuric acid excretion at 1029 ± 188 μmol/24 h [44], a 4.4-fold 
increase. The reasons for this are undoubtedly complex and diverse, one of which could be country-to-
country variations in the gut microbiota of the participating volunteers. A recent study examined a 
catalog of reference genes in the human gut microbiome of healthy Danish and Chinese individuals and 
found marked, country-specific differences in microbiota regarding many aspects of nutrient metabolism 
as well as xenobiotic detoxification [45], which, it was speculated, could have been shaped by diet and 
environment and other influences including host genetics. These are factors that are going to have to be 
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increasingly taken into account in studies on the ADME of dietary (poly)phenols and the involvement of 
the gut microbiome in potential beneficial effects on health.   
 
Summary 
The results show an extensive degradation of raspberry anthocyanins and ellagitannins as they 
pass through the body with a great variety of metabolites, including methyl-, glycine-, glucuronide- and 
sulfate derivatives of phenolic acids, phenylpropanoids, ellagic acid and urolithins. Anthocyanin and 
ellagitannin bioactivity is likely to be mediated by their phenolic metabolites as opposed to the parent 
structures. Unexpectedly, metabolism of anthocyanins appears to start in the upper GIT, possibly pH 
initiated, with 4’-hydroxyhippuric acid and ferulic acid derivatives circulating in plasma with a Cmax of 1-1.5 
h after consumption of raspberries. Previously, the formation of these compounds has been thought to 
be associated exclusively with the action of the colonic microflora.  Compounds originating from the 
ingested ellagitannins were principally phase II metabolites of the colon-derived urolithins A and B, 
which had plasma Cmax times of >24 h and were still being excreted in urine 32-48 h after the ingestion of 
raspberries indicating their high persistence in the body. Moreover, the amounts and type of urolithin 
conjugates produced differed considerably among the participants presumably as a consequence of 
variations in the microbial composition of their colonic microflora.  
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Fig. 1.  Structures of raspberry anthocyanins and the ellagitannins sanguiin H-6 and lambertianin.  
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Fig. 2.  UHPLC-MS-SRM traces of major phenolic metabolites identified in urine collected at 
various time points over a 48 h period after ingestion of 300 g of raspberries. Peak 
identification: 1 - 3',4'-dihydroxyphenyl acetic acid, 2 - 4'-hydroxyhippuric acid, 6 – 
hippuric acid, 11  - ferulic acid-4'-sulfate, 12 - ferulic acid, 13 - ferulic acid-4'-O-
glucuronide, 14 – isoferulic acid-3'-O-glucuronide, 15 - isoferulic acid-4'-sulfate, 16  - 
(Iso)urolithin A-sulfate-O-glucuronide, 17 - urolithin A-O-glucuronide, 18 - isourolithin A-O-
glucuronide, 19- urolithin A-sulfate, 20 - urolthin B-3-O-glucuronide, 21 - demethylellagic 
acid-O-glucuronide, 22 - urothin A, and  23 - urolithin B.   
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Fig. 3.  Pharmacokinetic profiles of anthocyanins in plasma following raspberry consumption. 
Data expressed as mean values ± SEM (cyandin-3-O-glucoside, n = 7; cyanidin-O-
glucuronide, n =3) 
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Fig. 4.  Pharmacokinetic profiles of ferulic acid metabolites in plasma following raspberry 
consumption. Data expressed as mean values ± SEM (n = 9)  
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Fig. 5.  Pharmacokinetic profiles of 3′,4′-dihydroxyphenylacetic acid , 4′-hippuric acid and hippuric 
acid in plasma following raspberry consumption. Data expressed as mean values ± SEM 
(hippuric acid and 4'-hydroxyhippuric acid, n = 9; 3',4'-dihydroxyphenylacetic acid, n = 7) 
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Fig. 6. Pharmacokinetic profiles of urolithins and ellagic acid derivatives in plasma following 
raspberry consumption. Data expressed as mean values ± SEM (urolithin A-O-glucuronide, 
n = 9; isourothin A-O-glucuronide, n = 4; urolithin A-sulfate, n = 8; isourolithin A-sulfate-O-
glucuronide, n = 5; urolithin B-3-O-glucuronide, n = 7; dimethylellagic acid-O-glucuronide, 
n = 9). 
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Fig. 7 Potential pathways for the metabolism of cyanidin-based anthocyanins following cleavage 
of the sugar moiety in the GIT after ingestion of raspberries.  It is assumed that the initial 
degradation step is the pH-mediated breakdown of cyanidin in the proximal GIT leading to the 
production of caffeic acid (black arrows).  Subsequent modification by shortening of the side chain 
and dehydroxylations, steps likely to be mediated by the colonic microbiota, are indicated with red 
arrows while blue arrows indicate phase II metabolism.  All compounds with the exception of 
caffeic acid, dihydrocaffeic acid, dihydroferulic acid and isoferulic acid were detected in plasma 
and/or urine. Compounds with boxed names indicate main components in that 48 h excretion 
after raspberry consumption increased by at least 1.0 μmol (see Table 2).  The proposed 
metabolism of caffeic acid is in keeping with the findings of Stamach et al. [25] who monitored the 
conversion caffeoylquinic acids in the proximal GIT to hydroxycinnamate derivatives, including 
caffeic acid, after the consumption of coffee 
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Table 1  
(Poly)phenolic compounds identified and quantified in raspberries by HPLC-
PDA-MSa  
(Poly)phenolic compounds  μmol per 300 g raspberries 
Cyanidin-3-O-sophoroside  175 ± 6 
Cyanidin-3-O-(2′′-O-glucosyl)rutinoside  56 ± 2 
Cyanidin-3-O-glucoside  37 ± 1 
Cyanidin-3-O-rutinoside  20 ± 1 
Cyanidin-3-O-(2′′-O-xylosyl)rutinoside  2.7 ± 0.1 
Pelargonidin-3-O-sophoroside  1.2 ± 0.0 
Pelargonidin-3-O-glucoside  1.1 ± 0.0 
Cyanidin-3,5-O-diglucoside traces 
Total anthocyanins 292 ± 10 
  Ellagic acid-O-pentoside  3.2 ± 0.2 
Ellagic acid-O-hexoside  3.1 ± 0.2 
Total ellagic acids 6.3 ± 0.3 
  Sanguiin H-6  195 ± 7 
Sanguiin H-10  5.7 ± 0.4 
Lambertianin C  50 ± 1 
Total ellagitannins 251 ± 3 
  Ferulic acid 1.2 ± 0.1 
4-Hydroxybenzoic acid  2.3 ± 0.1 
  Total (poly)phenols 553 ± 19 
a Data expressed as mean value ± S.E. (n=4). The berries did not contain 
detectable quantities of either caffeoylquinic, feruloylquinic or p-
coumaroylquinic acids.   
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Table 2  
Urinary excretion of anthocyanins and phenolic compounds 0-48 h after acute intake of 300 g blended 
raspberries containing 292 μmol of anthocyanins a,b 
Compounds Baselinec  0-4 h 4-8 h 8-24 h 24-32 h 32-48 h Total (0-48 h) 
Cyanidin-3-O-glucoside (nmol) - 9.3 ± 5.4 6.0 ± 3.1 4.6 ± 1.5 - - 19.9 ± 9.1* 
Peonidin-3-O-glucoside (nmol) - 0.9 ± 0.4 0.5 ± 0.2 - - - 1.4 ± 0.4* 
Total anthocyanins (nmol) - 10.2 ± 5.5 6.5 ± 3.2 4.6 ± 1.5   21.3 ± 9.28 
        4-Hydroxybenzoic acidb  - - 0.9 ± 0.9 - 1.6 ± 1.5 3.9 ± 3.7 6.4 ± 4.8* 
3,4-Dihydroxybenzoic acid - - - traces traces traces  
3-Methoxy-4-hydroxybenzoic acid - - - - - traces  
4-Hydroxybenzoic acid-3-sulfate 0.1 ± 0.0 - - 0.2 ± 0.1 traces 0.1 ± 0.0 0.3 ± 0.1* 
3-Hydroxybenzoic acid-4-sulfate 0.1 ± 0.0 - - 0.1 ± 0.0 traces 0.1 ± 0.0 0.2 ± 0.1* 
Total benzoic acid derivatives 0.2 ± 0.0 - 0.9 ± 0.9 0.3 ± 0.1 1.6 ± 1.5 4.1 ± 3.7 6.9 ± 5.0* 
        3',4'-Dihydroxyphenylacetic acid 0.4 ± 0.2 0.2 ± 0.1 0.5 ± 0.3 0.7 ± 0.4 0.5 ± 0.3 1.0 ± 0.6 2.9 ± 1.3* 
3′-Methoxy-4′-hydroxyphenylacetic acid  - - - traces 0.2 ± 0.2 - 0.2 ± 0.2 
Total phenylacetic acids 0.4 ± 0.2 0.2 ± 0.1 0.5 ± 0.3 0.7 ± 0.4 0.7 ± 0.5 1.0 ± 0.6 3.1 ± 1.7* 
        Caffeic acid-3’-sulfate traces 0.6 ± 0.1 0.2 ± 0.0 0.2 ± 0.1 traces traces 1.0 ± 0.1* 
Dihydrocaffeic acid-3’-sulfate traces 0.4 ± 0.1 0.1 ± 0.1 0.5 ± 0.2 0.1 ± 0.1 traces 1.1 ± 0.3* 
Ferulic acid 1.8 ± 0.3 0.9 ± 0.4 0.7 ± 0.2 1.9 ± 0.6 0.8 ± 0.4 1.6 ± 1.0 5.9 ± 2.1* 
Ferulic acid-4′-O-sulfate 1.6 ± 0.2 1.6 ± 0.5 0.8 ± 0.2 1.3 ± 0.6 0.8 ± 0.3 2.0 ± 1.3 6.5 ± 2.6* 
Isoferulic acid-3′-sulfate traces traces traces 0.2 ± 0.1 traces 0.3 ± 0.1  0.5 ± 0.2* 
Ferulic acid-4′-O-glucuronide 0.7 ± 0.1 0.6 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.2 0.3 ± 0.2 1.8 ± 0.5* 
Isoferulic acid-3′-O-glucuronide 0.3 ± 0.1 0.3 ± 0.1 0.2 ± 0.1 0.1 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 1.0 ± 0.4* 
Total phenylpropanoid derivatives 4.4 ± 0.6 3.8 ± 0.9 2.1 ± 0.4 4.3 ± 1.2 2.2 ± 0.9 4.4 ± 2.5 17.8 ± 5.3* 
        
4′-Hydroxyhippuric acid 7.0 ± 2.1 7.1 ± 1.0 3.3 ± 0.5 3.3 ± 1.3 1.6 ± 0.8 0.8 ± 0.5 16.1 ± 1.9* 
Hippuric acid 294 ± 47 100 ± 21 58 ± 19 26 ± 13 35 ± 18 20 ± 10 239 ± 55* 
        Total anthocyanin and phenolic acid 
derivatives (excluding hippuric acid) 12.0 ± 2.3 11.1 ± 1.8 6.8 ± 1.3 8.5 ± 2.6 6.1 ± 1.9 10.3 ± 4.3 
43.9 ± 8.0* 
(15.0%)d 
a Except for anthocyanins, data expressed as in μmol as mean values ± S.E. (n = 9) after subtraction of baseline excretion 
from each volunteer.  Anthocyanins expressed in nmol. 
b Detected only in the urine of 2 of 9 volunteers 
c Content of urine collected for 12 h prior to supplementation and on an excretion per hour basis used to subtract from 
excretion values obtained after raspberry consumption to obtain the values cited in the Table.    
d The amount excreted as a percentage of the dose of anthocyanins ingested 
- not detected 
* Significantly higher excretion on per hour basis from that at baseline (p ≤ 0.05). 
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Table 3  
Urinary excretion of urolithins and ellagic acid derivatives 0-48 h after acute intake of 300 g of blended 
raspberries containing a total of 257 µmol of ellagitannins and ellagic acid derivativesa 
Compound 
 Urinary excretion after intake of 300 g of raspberries (μmol) 
Baseline  0-4 h 4-8 h 8-24 h 24-32 h 32-48 h Total (48 h) 
Urolithin A - - - - - traces traces 
Urolithin B - - - - - traces traces 
Urolithin A-O-glucuronide  - - - 1.4 ± 0.6 1.0 ± 0.3 1.1 ±0.3 3.4 ± 1.2 
Isourolithin A-O-glucuronide - - - 0.2 ± 0.1 0.2 ± 0.1  0.4 ± 0.2 0.8 ± 0.4 
Urolithin A-sulfate - - - 2.4 ± 1.0 2.0 ± 0.9 2.3 ± 1.2 6.7 ± 3.2 
(Iso)urolithin A-sulfate-O-glucuronide - - - 0.3 ± 0.1 0.3 ± 0.1 0.2 ± 0.1 0.8 ± 0.2 
Urolithin B-3-O-glucuronide - - - 1.5 ± 0.9 1.5 ± 0.7 2.2 ± 0.9 5.2 ± 2.6 
Dimethylellagic acid-O-glucuronide - - - 0.4 ± 0.1 0.3 ± 01 0.3 ± 0.1 1.0  ± 0.2 
Total urolithins and ellagic acid derivatives 
   6.1 ± 1.5 
(2.4%) b 
5.4 ± 1.3 
(2.1%) b 
6.4 ± 1.9 
(2.5%) b 
17.9 ± 4.0 
(7.0%) b 
 a Data expressed as mean value ± S.E. (n=9). 
b numbers in parentheses represent the amount excreted as a percentage of the dose of ellagitannins ingested 
- not detected  
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Table 4  
Anthocyanins and their phenolic degradents identified and 
quantified in plasma after ingestion of 300 g of raspberries 
containing 292 μmol of anthocyanins a 
Compound nb Cmax (nmol/L) Tmax (h)c 
Cyanidin-3-O-glucoside  7 0.2 ± 0.1 1 
Cyanidin-O-glucuronide 3 0.1 ± 0.1 4 
    3',4'-Dihydroxyphenylacetic acid 7 180 ± 89 6 
    Ferulic acid-4′-sulfate 9 47 ± 14 1 
Ferulic acid-4′-O-glucuronide 9 18 ± 2 1.5 
Isoferulic acid-3'-O-glucuronide 9 14 ± 2 1.5 
    4'-Hydroxyhippuric acid 9 78 ± 12 1 
a Data expressed as mean value ± S.E. (n=9). 
b Metabolites detected in n = number of participants 
c Time to reach  Cmax  
 
 
 
 
 
 
Table 5  
Urolithins and ellagic acid metabolites identified and quantified in 
plasma after ingestion of 300 g of raspberriesa 
Compound nb Cmax (nmol/L) Tmax (h)c 
Urolithin A-O-glucuronide 9 24 ± 7 24 
Isourolithin A-O-glucuronide 4 4.5 ± 2.0 24 
Urolithin A-sulfate 8 450 ± 161 24 
(Iso)urolithin A-sulfate-O-glucuronide 5 5.5 ± 2.5 24 
Urolithin B-3-O-glucuronide 7 23 ± 14 24 
Dimethylellagic acid-O-glucuronide 8 3.5 ± 1.0 8 
a Data expressed as mean value ± S.E. (n=9). 
b Metabolites detected in n = number of participants 
c Time to reach  Cmax  
  
 
 
 
